Dalton Investments was recently referenced in Bloomberg’s coverage of the emerging buyout wave among Japan’s pharmaceutical companies following Hisamitsu Pharmaceutical’s decision to go private in a management buyout. Dalton has actively encouraged portfolio companies . . .
Buyout Wave Seen Among Japan Drugmakers After Hisamitsu Deal
Posted January 9, 2026